Mainsail Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$376K Buy
1,728
+638
+59% +$142K 0.17% 56
2025
Q4
$249K Sell
1,090
-392
-26% -$89.3K 0.11% 75
2025
Q3
$343K Buy
+1,482
New +$302K 0.15% 55

Other funds holding ABBV

Mainsail Asset Management's ABBV Position: Q1 2026 in Review

Mainsail Asset Management increased its AbbVie (ABBV) stake by 59% in Q1 2026, buying an estimated $142K and bringing the position to 1,728 shares worth $376K. The position accounts for 0.17% of the portfolio, ranked #56.

Mainsail Asset Management first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Mainsail Asset Management held 1,728 shares of AbbVie worth $376K as of Q1 2026.
  • Mainsail Asset Management bought 638 AbbVie shares in Q1 2026, an estimated $142K.
  • AbbVie made up 0.17% of Mainsail Asset Management's portfolio in Q1 2026, its #56 holding.
  • Mainsail Asset Management first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Mainsail Asset Management's 13F filing for Q1 2026, filed 13 May 2026.